Article Details

Omega Therapeutics Presents New Preclinical Data Supporting the Potential of OTX-2101 ...

Retrieved on: 2023-10-17 17:12:21

Tags for this article:

Click the tags to see associated articles and topics

Omega Therapeutics Presents New Preclinical Data Supporting the Potential of OTX-2101 .... View article details on hiswai:

Excerpt

(Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up